Study of CRX100 in Patients With Advanced Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colorectal Cancer
- Epithelial Ovarian Cancer
- Gastric Cancer
- Hepatocellular Carcinoma
- Osteosarcoma
- Solid Tumor, Adult
- Triple -Negative Breast Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04282044
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Oliver Dorigo, MD Stanford University
Get Well Soon